These findings are consistent with the results of a cohort study of COVID-19 patients hospitalized at the Mount Sinai Health System in New York, which showed elevated serum levels of IL-6, IL-8, and TNF-α on admission, and patients with higher cytokine levels exhibited greater disease severity and poorer survival rates [32]. This evidence concerns the gene CXCL8 and COVID-19.